Dr. Bruce Colston Trapnell, MD

Dr. Trapnell practices at UC Medical Center in Cincinnati, Ohio.

Dr. Trapnell's NPI, 1134177314, was assigned on May 4, 2006. Dr. Trapnell graduated from University of Maryland School of Medicine in 1984. Dr. Trapnell holds Ohio license 35-073928.

Dr. Trapnell's primary practice is UC Medical Center, at 3188 Bellevue Ave, Cincinnati, OH 45219 in Hamilton County. The practice phone is (513) 584-1000.

Dr. Trapnell's primary practice is UC Medical Center in Cincinnati, Ohio. Dr. Trapnell is also affiliated with University of Cincinnati Medical Center. The medical group on file is Cincinnati Children's. Dmand AI also links Dr. Trapnell to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trapnell practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Trapnell's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Trapnell is licensed in Ohio.

CMS data shows 28 Medicare services from Dr. Trapnell across 1 procedure code in 2024, all of them office visits, for 13 Medicare patients. Medicare paid $1,832 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 13 Medicare patients who saw Dr. Trapnell in 2024. The largest group is 85 and over, with 0 patients. 75% of them have copd. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Trapnell's median patient age at 54, with 45% women.

In 2024, Dr. Trapnell wrote 272 Medicare Part D claims for 20 patients. CMS names the drug for 135 of them, across 6 drugs with 11 or more claims each, at $608,208 in total drug cost. In 2023, CMS named 305 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Trapnell for performance year 2024, reported as part of a group. Dr. Trapnell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 89 papers to Dr. Trapnell, published from 2009 to 2025. 2016 was the busiest year, with 7. The most frequent topics are Pulmonary Alveolar Proteinosis, Granulocyte-Macrophage Colony-Stimulating Factor and Autoantibodies. Dr. Trapnell has published most often in Am J Respir Crit Care Med. Dr. Trapnell's most frequent co-authors are Lee A. Denson, MD, Mark Louis Brantly, MD and Lisa Rosenthal Young, MD.

Dmand AI links Dr. Trapnell to 4 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Pulmonary Alveolar Proteinosis, Acquired, alpha 1-Antitrypsin Deficiency and Lymphangioleiomyomatosis.

CMS Open Payments shows 63 general payments to Dr. Trapnell from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 91% of the total. GlaxoSmithKline, LLC. paid the most, $75,031. It also lists 1 research payment totaling $438 in 2023.

Dr. Trapnell graduated from University of Maryland School of Medicine in 1984.